Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GERON CORPGERN · Entity 4989 | EVP, Chief Financial Officer | August 15, 2023 | September 22, 2023 |
| Personalis, Inc.PSNL · Entity 4572 | Director | May 12, 2026 | May 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GERON CORP
Report date August 15, 2023 · Filed September 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.72 · Expires 2028-11-06 | Direct | 250,000 |
Reported balance
After 2023-08-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-08-15 · Grant · Acquired 250,000 · Balance 250,000 F1: Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS.
Personalis, Inc.
Report date May 12, 2026 · Filed May 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,265 |
Reported balance
After 2026-05-12 transaction · row 1
1 source rowRow 1 · 2026-05-12 · Grant · Acquired 6,250 · Balance 27,265 F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan (the "2019 Plan")) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such Change in Control. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.04 · Expires 2036-05-12 | Direct | 37,500 |
Reported balance
After 2026-05-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-12 · Grant · Acquired 37,500 · Balance 37,500 F2: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the 2019 Plan) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan (the "2019 Plan")) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such Change in Control.
F2: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the 2019 Plan) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 12, 2026 Filed May 14, 2026 21:05 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0001501545-26-000001 · form4-05142026_090558.xml · derivative · entry 2 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2036-05-12 F2 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the 2019 Plan) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control. Read SEC document |
| May 12, 2026 Filed May 14, 2026 21:05 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001501545-26-000001 · form4-05142026_090558.xml · nonDerivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,265 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan (the "2019 Plan")) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such Change in Control. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:18 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0001415889-25-013801 · form4-05202025_080517.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-16 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control. Read SEC document |
| May 17, 2024 Filed May 22, 2024 01:19 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001415889-24-014042 · form4-05222024_010500.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| August 15, 2023 Filed Sep 22, 2023 00:31 UTC | GERON CORP GERN · Entity 4989 | GrantEmployee Stock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001062993-23-018390 · form4.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2028-11-06 F1 · date: Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS. F1 · derivative.exercise_date: Performance-based stock option granted on November 7, 2018 and vested in full on August 15, 2023 upon acceptance of the NDA by the US FDA for imetelstat in lower risk MDS. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:59 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $2.07 | $0.00 |
DisclosureSEC source: 0001209191-23-031251 · doc4.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-05-17 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 00:17 UTC | GERON CORP GERN · Entity 4989 | GrantEmployee Stock Option (right to buy) · Derivative | 575,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001062993-23-004899 · form4.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 575,000 Underlying: Common Stock · 575,000 shares Expires 2033-02-21 F1 · derivative.exercise_date: This option vests in a series of 48 consecutive equal monthly installments commencing February 22, 2023, provided the optionee continues to provide services to the Company. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 02:48 UTC | GERON CORP GERN · Entity 4989 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001062993-23-002792 · form4.xml · derivative · entry 3 Bloom Olivia Kyusuk · CIK 0001501545 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400,000 shares Expires 2023-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction reflects an exercise and sale of options due to expire on February 12, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023. F1 · derivative.exercise_date: Option was fully vested. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 02:48 UTC | GERON CORP GERN · Entity 4989 | SaleCommon Stock | 400,000 | $3.08 | $1,232,000.00 |
DisclosureSEC source: 0001062993-23-002792 · form4.xml · nonDerivative · entry 2 Bloom Olivia Kyusuk · CIK 0001501545 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,588 F2 · kind: This transaction reflects an exercise and sale of options due to expire on February 12, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 02:48 UTC | GERON CORP GERN · Entity 4989 | Exercise / conversionCommon Stock | 400,000 | $1.51 | $604,000.00 |
DisclosureSEC source: 0001062993-23-002792 · form4.xml · nonDerivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction reflects an exercise and sale of options due to expire on February 12, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023. Read SEC document |
| May 17, 2022 Filed May 19, 2022 23:50 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (right to buy) · Derivative | 15,035 | $0.00 Strike: $4.81 | $0.00 |
DisclosureSEC source: 0001209191-22-030776 · doc4.xml · derivative · entry 2 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,035 Underlying: Common Stock · 15,035 shares Expires 2032-05-17 F2 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 17, 2022 Filed May 19, 2022 23:50 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantCommon Stock | 10,770 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030776 · doc4.xml · nonDerivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,015 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such change in control. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:55 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantCommon Stock | 10,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014995 · doc4.xml · nonDerivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,245 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 3 annual installments with the first installment vesting on March 1, 2023. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 23:06 UTC | GERON CORP GERN · Entity 4989 | GrantEmployee Stock Option (right to buy) · Derivative | 750,000 | $0.00 Strike: $1.06 | $0.00 |
DisclosureSEC source: 0001062993-22-005007 · form4.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2032-02-15 F1 · derivative.exercise_date: This option vests in a series of 48 consecutive equal monthly installments commencing February 16, 2022, provided the optionee continues to provide services to the Company. Read SEC document |
| March 01, 2021 Filed Mar 2, 2022 22:55 UTC | Personalis, Inc. PSNL · Entity 4572 | GrantStock Option (Right to Buy) · Derivative | 15,691 | $0.00 Strike: $10.17 | $0.00 |
DisclosureSEC source: 0001209191-22-014995 · doc4.xml · derivative · entry 2 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,691 Underlying: Common Stock · 15,691 shares Expires 2032-03-01 F2 · derivative.exercise_date: The shares subject to the option vest in 3 annual installments with the first installment vesting on March 1, 2023. Read SEC document |
| February 02, 2021 Filed Feb 5, 2021 00:46 UTC | GERON CORP GERN · Entity 4989 | GrantEmployee Stock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0000886744-21-000017 · edgar.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2031-02-01 F1 · derivative.exercise_date: This option vests in a series of 48 consecutive equal monthly installments commencing February 2, 2021, provided the optionee continues to provide services to the Company. Read SEC document |
| February 12, 2020 Filed Feb 15, 2020 00:38 UTC | GERON CORP GERN · Entity 4989 | GrantEmployee Stock Option (right to buy) · Derivative | 291,375 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0000886744-20-000027 · edgar.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,375 Underlying: Common Stock · 291,375 shares Expires 2030-02-11 F1 · derivative.exercise_date: This option vests in a series of 48 consecutive equal monthly installments commencing February 12, 2020, provided the optionee continues to provide services to the Company. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 23:23 UTC | GERON CORP GERN · Entity 4989 | GrantEmployee Stock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $1.03 | $0.00 |
DisclosureSEC source: 0000886744-19-000018 · edgar.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2029-01-29 F1 · derivative.exercise_date: This option vests in a series of 48 consecutive equal monthly installments commencing January 30, 2019 provided the optionee continues to provide services to the Company. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 23:06 UTC | GERON CORP GERN · Entity 4989 | GrantEmployee Stock Option (right to buy) · Derivative | 350,000 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0000886744-18-000015 · edgar.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2028-01-31 F1 · derivative.exercise_date: This option vests in a series of 48 consecutive equal monthly installments commencing January 31, 2018 provided the optionee continues to provide services to the Company. Read SEC document |
| February 09, 2017 Filed Feb 11, 2017 00:53 UTC | GERON CORP GERN · Entity 4989 | GrantEmployee Stock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0000886744-17-000009 · edgar.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2027-02-09 F1 · derivative.exercise_date: This option vests in a series of 48 consecutive equal monthly installments commencing February 9, 2017 provided the optionee continues to provide services to the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.